Atkinson Edward Morrow III sold VRTX
February 18, 2026 · Form 4 insider transaction
Atkinson Edward Morrow III sold 817 shares of Vertex Pharmaceuticals Incorporated at $473.68 per share, a transaction worth $387.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
817
Price
$473.68
Total value
$387.0K
InsiderAtkinson Edward Morrow III
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 18, 2026
Filing dateFebruary 19, 2026
Shares owned after20,727
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025.